fenoldopam has been researched along with nifedipine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Berger, J; Gombotz, H; Mahla, E; Metzler, H; Plaza, J | 1 |
Marik, PE; Varon, J | 1 |
2 review(s) available for fenoldopam and nifedipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The diagnosis and management of hypertensive crises.
Topics: Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Clonidine; Diazoxide; Enalaprilat; Female; Fenoldopam; Humans; Hypertension; Labetalol; Nicardipine; Nifedipine; Nitroprusside; Phentolamine; Pre-Eclampsia; Pregnancy; Propanolamines; Trimethaphan | 2000 |
1 trial(s) available for fenoldopam and nifedipine
Article | Year |
---|---|
DA1-receptor stimulation by fenoldopam in the treatment of postcardiac surgical hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Catheterization, Central Venous; Coronary Artery Bypass; Dopamine Agonists; Drug Administration Schedule; Female; Fenoldopam; Heart Rate; Hemodynamics; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Nifedipine; Pulmonary Artery; Receptors, Dopamine; Stroke Volume; Thermodilution; Vascular Resistance; Ventricular Function, Right | 1998 |
1 other study(ies) available for fenoldopam and nifedipine
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |